Arbutus Biopharma

In News

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability - Yahoo Finance

Yahoo Finance - Apr 17, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

DirectorsTalk Interviews - May 08, 2026

[8-K] Arbutus Biopharma Corp Reports Material Event - Stock Titan

Stock Titan - Apr 15, 2026

ABUS Stock Price, Quote & Chart | ARBUTUS BIOPHARMA CORP (NASDAQ:ABUS) - ChartMill

ChartMill - May 06, 2026

Arbutus shares jump after FDA grants fast track status to hepatitis B therapy - MSN

MSN - Apr 26, 2026

Arbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed | ABUS Stock News - Quiver Quantitative

Quiver Quantitative - Apr 15, 2026

Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - Feb 03, 2026

Arbutus Biopharma Gains FDA Fast Track for Imdusiran - TipRanks

TipRanks - Apr 15, 2026

Chardan reiterates Arbutus Biopharma stock rating on Moderna deal - Investing.com

Investing.com - Mar 04, 2026

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran - Yahoo Finance

Yahoo Finance - Apr 23, 2026

Whitefort lifts Arbutus (ABUS) economic stake to 9.8% - Stock Titan

Stock Titan - Apr 28, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment